Who owns ALIGOS THERAPEUTICS INC?
- Ticker: ALGS
- CUSIP Number: 01626l105
Tip: Access positions for across all investors
Analyze quarterly positions in Aligos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aligos Therapeutics stock
Who bought or sold ALIGOS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Alyeska Investment Group | 9.0M | $6.0M | 100% | Dec 2023 |
|
| EcoR1 Capital | 6.4M | $4.2M | 62% | Dec 2023 |
|
| Vivo Capital | 3.5M | $2.4M | 0% | Dec 2023 |
|
| Altitude Crest Partners | 2.8M | $1.9M | 100% | Dec 2023 |
|
| Versant Venture Management | 2.3M | $1.5M | 0% | Dec 2023 |
|
| Tang Capital Management | 2.2M | $1.5M | -34% | Dec 2023 |
|
| Baker Bros. Advisors | 2.1M | $1.4M | 0% | Dec 2023 |
|
| Hillhouse Capital Advisors | 1.9M | $1.3M | -17% | Dec 2023 |
|
| Opaleye Management | 1.3M | $861k | 100% | Dec 2023 |
|
| Newtyn Management | 1.3M | $833k | 36% | Dec 2023 |
|
| Bank of America Corporation | 1.1M | $762k | 0% | Dec 2023 |
|
| Vanguard Group | 1.0M | $672k | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 31k | $21k | 0% | Dec 2023 |
|
| Millennium Management | 29k | $19k | -69% | Dec 2023 |
|
| Procyon Private Wealth Partners | 20k | $20k | 100% | Mar 2024 |
|
| Two Sigma Investments | 19k | $12k | -19% | Dec 2023 |
|
| CWM | 17k | $17k | 0% | Mar 2024 |
|
| Two Sigma Securities | 15k | $9.8k | 100% | Dec 2023 |
|
| Zullo Investment Group | 13k | $8.6k | 100% | Dec 2023 |
|
| Creative Planning | 10k | $6.7k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 677.00 | $450.001900 | 0% | Dec 2023 |
|
| Royal Bank of Canada | 441.00 | $0 | -100% | Dec 2023 |
|
| Wells Fargo & Company | 293.00 | $194.991500 | 50% | Dec 2023 |
|
| Zrc Wealth Management | 100.00 | $75.000000 | 0% | Dec 2023 |
|
Who sold out of Aligos Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Sep 2023 | 5.4k | $4.0k |
| Federated Investors | Sep 2023 | 653.00 | $487.986900 |